AMG 581
/ Amgen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 22, 2015
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
(clinicaltrials.gov)
- P1; N=52; Not yet recruiting; Sponsor: Amgen
New P1 trial • Biosimilar • Schizophrenia
1 to 1
Of
1
Go to page
1